Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
31	[KR] Improved modalities for the treatment of degenerative diseases of the retina (Registration number 10-1398356)
30	[KR] Method for expansion and purification of human embryonic stem cell-derived cardiomyocyte (Registration number 10-1364965)
29	[KR] Injection needle for injecting stem cells and syringe equipped therewith (Registration number 10-1322673)
28	[KR] Process for preparing lymphocytes comprising activated natural killer cells for targeting cancer cells and pharmaceutical composition comprising the same
27	[KR] System for operating stem cell bank by using internet and method thereof (Registration number 10-1295803)
26	[KR] Cosmetic composition comprising growth factor and cytokine induced human placenta (Registration number 10-1289062)
25	[KR] Pharmaceutical composition for preventing or treating gastrointestinal damage comprising kauran derivatives (Registration number 10-1282003)
24	[KR] Improved modalities for the treatment of degenerativediseases of the retina (Registration number 10-1258292)
23	[KR] Cosmetic composition comprising hydrolysate of silkworm silkgland and thereof (Registration number 10-1252538)
22	[KR] Composition for promoting hair growth comprising culture or its fractions of the epidermal skin stem cells (Registration number 10-1172288)